Page last updated: 2024-10-15

acyclovir triphosphate

Cross-References

ID SourceID
PubMed CID135405018
CHEMBL ID1673
SCHEMBL ID14095557
MeSH IDM0084119

Synonyms (21)

Synonym
[2-[(2-amino-6-oxo-1h-purin-9-yl)methoxy]ethoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate
9-(2-hydroxyethoxymethyl)guanine triphosphate
triphosphoric acid, p-[2-[(2-amino-1,6-dihydro-6-oxo-9h-purin-9-yl)methoxy]ethyl] ester
acyclovir triphosphate
acycloguanosine triphosphate
acyclogtp
66341-18-2
aciclovir-triphosphate
triphosphoric acid, mono[2-[(2-amino-3,6-dihydro-6-oxo-9h-purin-9-yl)methoxy]ethyl] ester
triphosphoric acid, p-[2-[(2-amino-1,6-dihydro-6-oxo-9h-purin-9-yl)methoxy]ethyl] ester (9ci)
acgtp
aciclvir-triphosphate
triphosphoric acid, p-(2-((2-amino-1,6-dihydro-6-oxo-9h-purin-9-yl)methoxy)ethyl) ester
[2-[(2-amino-6-oxo-3h-purin-9-yl)methoxy]ethoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate
CHEMBL1673
SCHEMBL14095557
DTXSID30216551
bdbm50478747
acv-tp
Q27458091
[2-[(2-amino-6-oxo-1h-purin-9-yl)methoxy]ethoxy-hydroxyphosphoryl] phosphono hydrogen phosphate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA polymerase subunit gamma-1Homo sapiens (human)Kd6.00000.80003.40006.0000AID357985
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (7)

Processvia Protein(s)Taxonomy
base-excision repair, gap-fillingDNA polymerase subunit gamma-1Homo sapiens (human)
DNA metabolic processDNA polymerase subunit gamma-1Homo sapiens (human)
DNA-templated DNA replicationDNA polymerase subunit gamma-1Homo sapiens (human)
mitochondrial DNA replicationDNA polymerase subunit gamma-1Homo sapiens (human)
base-excision repairDNA polymerase subunit gamma-1Homo sapiens (human)
DNA replication proofreadingDNA polymerase subunit gamma-1Homo sapiens (human)
DNA biosynthetic processDNA polymerase subunit gamma-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protease bindingDNA polymerase subunit gamma-1Homo sapiens (human)
DNA bindingDNA polymerase subunit gamma-1Homo sapiens (human)
chromatin bindingDNA polymerase subunit gamma-1Homo sapiens (human)
DNA-directed DNA polymerase activityDNA polymerase subunit gamma-1Homo sapiens (human)
protein bindingDNA polymerase subunit gamma-1Homo sapiens (human)
single-stranded DNA 3'-5' DNA exonuclease activityDNA polymerase subunit gamma-1Homo sapiens (human)
3'-5' exonuclease activityDNA polymerase subunit gamma-1Homo sapiens (human)
5'-deoxyribose-5-phosphate lyase activityDNA polymerase subunit gamma-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
mitochondrionDNA polymerase subunit gamma-1Homo sapiens (human)
mitochondrial matrixDNA polymerase subunit gamma-1Homo sapiens (human)
gamma DNA polymerase complexDNA polymerase subunit gamma-1Homo sapiens (human)
mitochondrial nucleoidDNA polymerase subunit gamma-1Homo sapiens (human)
intracellular membrane-bounded organelleDNA polymerase subunit gamma-1Homo sapiens (human)
protein-containing complexDNA polymerase subunit gamma-1Homo sapiens (human)
mitochondrionDNA polymerase subunit gamma-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID359811Ratio of polymerization constant K to Kd for human recombinant DNA polymerase gamma E200A mutant2007The Journal of biological chemistry, Aug-24, Volume: 282, Issue:34
Enzymatic therapeutic index of acyclovir. Viral versus human polymerase gamma specificity.
AID52059Inhibitory [3H]GDP concentration against cellular p21 Ha-ras1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
Interaction of GTP derivatives with cellular and oncogenic ras-p21 proteins.
AID357985Binding affinity to exonuclase deficient human recombinant DNA polymerase gamma E200A mutant2007The Journal of biological chemistry, Aug-24, Volume: 282, Issue:34
Enzymatic therapeutic index of acyclovir. Viral versus human polymerase gamma specificity.
AID359810Polymerizing activity of exonuclase deficient human recombinant DNA polymerase gamma E200A mutant assessed as rate of nucleotide incorporation by pre-steady state single nucleotide incorporation assay2007The Journal of biological chemistry, Aug-24, Volume: 282, Issue:34
Enzymatic therapeutic index of acyclovir. Viral versus human polymerase gamma specificity.
AID359795Polymerizing activity of exonuclase deficient HSV1 DNA polymerase UL42 D368A mutant assessed as rate of nucleotide incorporation by pre-steady state single turnover assay2007The Journal of biological chemistry, Aug-24, Volume: 282, Issue:34
Enzymatic therapeutic index of acyclovir. Viral versus human polymerase gamma specificity.
AID359797Ratio of polymerization constant K to Kd for exonuclase deficient HSV1 DNA polymerase UL42 D368A mutant2007The Journal of biological chemistry, Aug-24, Volume: 282, Issue:34
Enzymatic therapeutic index of acyclovir. Viral versus human polymerase gamma specificity.
AID359796Binding affinity to exonuclase deficient HSV1 DNA polymerase UL42 D368A mutant2007The Journal of biological chemistry, Aug-24, Volume: 282, Issue:34
Enzymatic therapeutic index of acyclovir. Viral versus human polymerase gamma specificity.
AID145921Inhibitory [3H]GDP concentration against oncogenic Ha-ras protein (p21 Leu-61)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
Interaction of GTP derivatives with cellular and oncogenic ras-p21 proteins.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (66.67)18.7374
1990's7 (23.33)18.2507
2000's3 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.33%)5.53%
Reviews3 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]